DNMT3A and hematologic disorder: No significant difference in gender, antecedent hematologic disorder, RBC (red blood cells) and neutrophil counts, hemoglobin and lactate dehydrogenase (LDH) levels, or percentages of blast cells in bone marrow was observed at diagnosis between patients with and without the DNMT3A R882 mutations.